Economic evaluation of medicines.
作者信息
Taylor Colman, Jan Stephen
机构信息
Optum, Sydney.
Sydney Medical School, University of Sydney.
出版信息
Aust Prescr. 2017 Apr;40(2):76-78. doi: 10.18773/austprescr.2017.014. Epub 2017 Apr 3.
Abstract
摘要
相似文献
1
Economic evaluation of medicines.药品的经济学评估。
Aust Prescr. 2017 Apr;40(2):76-78. doi: 10.18773/austprescr.2017.014. Epub 2017 Apr 3.
2
[International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].[哥伦比亚药品价格监管的国际参考价格与成本最小化分析]
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S16-9. doi: 10.1016/j.jval.2011.05.034.
3
Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.作为补贴决策辅助手段的经济分析：澳大利亚药品指南的制定
Pharmacoeconomics. 1992 Jan;1(1):54-67. doi: 10.2165/00019053-199201010-00010.
4
Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.2005 年至 2015 年坦桑尼亚不合规和假冒伪劣人用药品及含禁用成分化妆品的经济成本：监管机构数据的回顾性分析。
BMJ Open. 2018 Jun 27;8(6):e021825. doi: 10.1136/bmjopen-2018-021825.
5
The UK pharmaceutical market. An overview.英国制药市场。概述。
Pharmacoeconomics. 1996;10 Suppl 2:14-25. doi: 10.2165/00019053-199600102-00005.
6
Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.作为修辞学的卫生经济学：卫生经济学对四个欧洲国家资金决策的有限影响
Value Health. 2016 Dec;19(8):951-956. doi: 10.1016/j.jval.2016.08.001. Epub 2016 Sep 19.
7
How much is the life of a cancer patient worth? A pharmaco-economic perspective.癌症患者的生命价值几何？从药物经济学角度来看。
J Clin Pharm Ther. 2011 Jun;36(3):249-56. doi: 10.1111/j.1365-2710.2010.01181.x. Epub 2010 Aug 24.
8
Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa.南非比勒陀利亚的参保消费者在零售药店为药品支付自付费用的原因。
Afr J Prim Health Care Fam Med. 2019 Mar 27;11(1):e1-e6. doi: 10.4102/phcfm.v11i1.1878.
9
Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.澳大利亚药品福利计划中所列药品定价安排的透明度。
Aust Health Rev. 2009 May;33(2):192-9. doi: 10.1071/ah090192.
10
[Advances and experiences in economic evaluation of medicines: a complementary view].[药品经济评估的进展与经验：一种补充观点]
Gac Sanit. 2008 Jul-Aug;22(4):358-61. doi: 10.1157/13125359.
引用本文的文献
1
Are joint replacement registries cost-effective? Economic evaluation of the Australian orthopaedic association National joint replacement registry.关节置换登记处具有成本效益吗？澳大利亚骨科协会国家关节置换登记处的经济评估。
Arch Orthop Trauma Surg. 2025 Aug 12;145(1):408. doi: 10.1007/s00402-025-06029-x.
2
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis.患者与医疗保健系统在皮肤利什曼病控制中的相互作用
Transbound Emerg Dis. 2023 Aug 26;2023:7814940. doi: 10.1155/2023/7814940. eCollection 2023.
3
Photobiomodulation in Ophthalmology: A Comprehensive Review of Bench-to-Bedside Research and Clinical Integration.眼科中的光生物调节：从实验室到临床研究与临床整合的全面综述
Cureus. 2024 Sep 18;16(9):e69651. doi: 10.7759/cureus.69651. eCollection 2024 Sep.
4
Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee.《唤醒死者：对澳大利亚药品福利咨询委员会健康技术评估提交物中成本最小化方法的评价》
Pharmacoeconomics. 2024 Nov;42(11):1287-1300. doi: 10.1007/s40273-024-01420-9. Epub 2024 Aug 24.
5
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment.基于模型的痴呆干预措施经济学评价：一项更新的系统评价和质量评估。
Appl Health Econ Health Policy. 2024 Jul;22(4):503-525. doi: 10.1007/s40258-024-00878-0. Epub 2024 Mar 30.
6
A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus.一项关于孕期由营养师提供的电话指导项目预防妊娠期糖尿病的成本效益评估。
Cost Eff Resour Alloc. 2024 Mar 1;22(1):18. doi: 10.1186/s12962-024-00520-9.
7
Systematic Review of the Economic Evaluation of Sodium-Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure.钠-葡萄糖共转运蛋白 2 抑制剂治疗心力衰竭的经济学评价的系统评价。
Clin Drug Investig. 2023 Jul;43(7):463-474. doi: 10.1007/s40261-023-01283-6. Epub 2023 Jun 26.
8
Tissue and Cell Donation: Recommendations From an International Consensus Forum.组织与细胞捐赠：国际共识论坛的建议
Transplant Direct. 2023 Apr 28;9(5):e1466. doi: 10.1097/TXD.0000000000001466. eCollection 2023 May.
9
The cost-effectiveness of digital health interventions: A systematic review of the literature.数字健康干预措施的成本效益：文献系统评价。
Front Public Health. 2022 Aug 11;10:787135. doi: 10.3389/fpubh.2022.787135. eCollection 2022.
10
Health Economic Aspects of Childhood Excess Weight: A Structured Review.儿童超重的健康经济问题：一项结构化综述。
Children (Basel). 2022 Mar 24;9(4):461. doi: 10.3390/children9040461.
本文引用的文献
1
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).成本效益分析与决策的一致性：来自澳大利亚药品报销的证据（1991年至1996年）
Pharmacoeconomics. 2001;19(11):1103-9. doi: 10.2165/00019053-200119110-00004.
Zotero 插件